Potassium Salt [EPC]

Potassium Salt [EPC] was reported 93830 times

Drugs of the Potassium Salt [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 184 0.6073
1 APPENDICOLITH 211 0.5452
2 SLEEP DISORDER THERAPY 103 0.5202
3 ANALGESIC THERAPY 100 0.3115
4 DRUG THERAPY 93 0.2743
5 DEVICE MAINTENANCE ISSUE 86 0.1463
6 FEMALE GENITAL TRACT FISTULA 200 0.1170
7 RADICULOPATHY 243 0.0921
8 HYPERPHOSPHATAEMIA 174 0.0809
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 79 0.0744
10 INFUSION SITE DISCHARGE 130 0.0741
11 PROCTITIS 199 0.0710
12 CHRONIC SINUSITIS 262 0.0697
13 CARDIOACTIVE DRUG LEVEL INCREASED 91 0.0692
14 LEFT ATRIAL DILATATION 83 0.0650
15 OESOPHAGEAL SPASM 119 0.0645
16 BLOOD PHOSPHORUS INCREASED 176 0.0644
17 HYPERPARATHYROIDISM SECONDARY 151 0.0602
18 INFUSION SITE INFECTION 138 0.0593
19 METABOLIC ALKALOSIS 92 0.0573
20 NEPHROGENIC ANAEMIA 262 0.0565
21 ESSENTIAL HYPERTENSION 103 0.0562
22 ORTHOPNOEA 168 0.0527
23 HYPERVOLAEMIA 260 0.0526
24 INFUSION SITE HAEMORRHAGE 170 0.0516
25 DEVICE INFUSION ISSUE 128 0.0516
26 OBSTRUCTIVE SLEEP APNOEA SYNDROME 74 0.0507
27 AORTIC STENOSIS 176 0.0505
28 INFUSION SITE INDURATION 73 0.0492
29 OXYGEN CONSUMPTION INCREASED 111 0.0464
30 COLITIS MICROSCOPIC 212 0.0447
31 THERAPEUTIC AGENT TOXICITY 149 0.0446
32 HYPOKALAEMIA 2044 0.0442
33 RIGHT VENTRICULAR FAILURE 307 0.0438
34 BLOOD CHLORIDE DECREASED 111 0.0430
35 VASCULAR DEVICE INFECTION 194 0.0427
36 ISCHAEMIC CARDIOMYOPATHY 130 0.0424
37 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 212 0.0418
38 INFUSION SITE PAIN 537 0.0416
39 LYMPHOEDEMA 284 0.0410
40 BRAIN NATRIURETIC PEPTIDE INCREASED 125 0.0405
41 CATHETER SITE ERYTHEMA 86 0.0401
42 HAEMORRHAGIC ANAEMIA 175 0.0398
43 INFUSION SITE ERYTHEMA 334 0.0396
44 BREATH SOUNDS ABNORMAL 194 0.0393
45 CATHETER SITE HAEMORRHAGE 97 0.0387
46 HYPOPHOSPHATAEMIA 280 0.0378
47 INFUSION SITE SWELLING 238 0.0378
48 BLOOD POTASSIUM DECREASED 1137 0.0378
49 ATELECTASIS 365 0.0377
50 RALES 213 0.0366
51 HAEMOGLOBIN INCREASED 166 0.0364
52 VENTRICULAR FIBRILLATION 403 0.0362
53 INFUSION SITE REACTION 107 0.0358
54 PULMONARY HYPERTENSION 738 0.0354
55 MACULAR DEGENERATION 423 0.0354
56 REBOUND ACID HYPERSECRETION 104 0.0343
57 IRON DEFICIENCY 153 0.0340
58 HYPOVOLAEMIA 199 0.0340
59 MITRAL VALVE INCOMPETENCE 380 0.0335
60 CARDIOMEGALY 411 0.0334
61 CARDIOGENIC SHOCK 474 0.0330
62 SUPRAVENTRICULAR EXTRASYSTOLES 111 0.0328
63 BLOOD LOSS ANAEMIA 74 0.0326
64 METABOLIC ENCEPHALOPATHY 98 0.0326
65 HYPERLIPIDAEMIA 388 0.0324
66 TRICUSPID VALVE INCOMPETENCE 257 0.0323
67 HYPERKALAEMIA 1129 0.0322
68 ATRIOVENTRICULAR BLOCK FIRST DEGREE 139 0.0320
69 ATRIAL FLUTTER 255 0.0319
70 LEFT VENTRICULAR FAILURE 110 0.0319
71 OESOPHAGEAL PAIN 125 0.0316
72 PLEURITIC PAIN 87 0.0315
73 ACUTE RESPIRATORY FAILURE 605 0.0314
74 FAILURE TO THRIVE 161 0.0310
75 BLOOD URIC ACID INCREASED 178 0.0308
76 SEASONAL ALLERGY 432 0.0305
77 MULTIPLE INJURIES 192 0.0305
78 BLOOD POTASSIUM ABNORMAL 80 0.0300
79 LUNG CONSOLIDATION 82 0.0293
80 LEFT VENTRICULAR HYPERTROPHY 124 0.0289
81 PROTHROMBIN TIME PROLONGED 173 0.0289
82 APPENDICITIS 270 0.0289
83 HYPERCAPNIA 87 0.0289
84 FLUID OVERLOAD 420 0.0288
85 BLOOD MAGNESIUM DECREASED 249 0.0288
86 INFUSION SITE PRURITUS 91 0.0288
87 DIASTOLIC DYSFUNCTION 89 0.0288
88 HYPOMAGNESAEMIA 401 0.0288
89 LUNG OPACITY 74 0.0281
90 ELECTROLYTE IMBALANCE 325 0.0279
91 PULMONARY ARTERIAL HYPERTENSION 393 0.0271
92 CLOSTRIDIUM DIFFICILE COLITIS 286 0.0269
93 AORTIC VALVE INCOMPETENCE 114 0.0268
94 BUNDLE BRANCH BLOCK LEFT 113 0.0266
95 CARDIAC FAILURE CONGESTIVE 2133 0.0265
96 END STAGE RENAL DISEASE 484 0.0265
97 MYASTHENIA GRAVIS 214 0.0265
98 HYPERNATRAEMIA 132 0.0265
99 ECONOMIC PROBLEM 397 0.0262
100 BLOOD UREA INCREASED 435 0.0260
101 ORAL CANDIDIASIS 342 0.0259
102 LOWER GASTROINTESTINAL HAEMORRHAGE 191 0.0258
103 BLOOD ALBUMIN DECREASED 203 0.0256
104 BENIGN PROSTATIC HYPERPLASIA 132 0.0255
105 INTERNATIONAL NORMALISED RATIO DECREASED 103 0.0254
106 RENAL FAILURE CHRONIC 195 0.0253
107 FLUID RETENTION 1278 0.0251
108 CHEST X-RAY ABNORMAL 77 0.0251
109 CARDIAC MURMUR 216 0.0249
110 ARTERIOSCLEROSIS CORONARY ARTERY 165 0.0249
111 TROPONIN INCREASED 189 0.0248
112 DYSPNOEA EXERTIONAL 934 0.0248
113 LUNG INFILTRATION 218 0.0247
114 MULTIPLE ALLERGIES 190 0.0242
115 CYTOKINE RELEASE SYNDROME 486 0.0242
116 CARDIAC FAILURE CHRONIC 103 0.0241
117 PERIPHERAL VASCULAR DISORDER 124 0.0240
118 ASCITES 707 0.0240
119 CONGESTIVE CARDIOMYOPATHY 100 0.0240
120 HYPOXIA 840 0.0238
121 HEPARIN-INDUCED THROMBOCYTOPENIA 117 0.0237
122 TOXIC EPIDERMAL NECROLYSIS 358 0.0236
123 ELECTROCARDIOGRAM ABNORMAL 184 0.0234
124 CATHETER SITE INFECTION 88 0.0232
125 INTERNATIONAL NORMALISED RATIO INCREASED 662 0.0232
126 GOUT 416 0.0232
127 DERMATITIS CONTACT 264 0.0231
128 PROTEIN TOTAL DECREASED 87 0.0231
129 VENTRICULAR EXTRASYSTOLES 239 0.0230
130 VENTRICULAR TACHYCARDIA 380 0.0230
131 CARDIAC FAILURE ACUTE 153 0.0229
132 PULSE ABSENT 109 0.0229
133 PNEUMONIA ASPIRATION 567 0.0227
134 DIVERTICULUM 161 0.0226
135 PEPTIC ULCER 75 0.0226
136 ATRIAL FIBRILLATION 2190 0.0225
137 RED CELL DISTRIBUTION WIDTH INCREASED 93 0.0224
138 CAROTID ARTERY STENOSIS 78 0.0223
139 LEFT VENTRICULAR DYSFUNCTION 149 0.0222
140 HYPOALBUMINAEMIA 171 0.0220
141 EXERCISE TOLERANCE DECREASED 126 0.0219
142 IRON DEFICIENCY ANAEMIA 202 0.0219
143 RENAL FAILURE ACUTE 928 0.0218
144 MALNUTRITION 240 0.0214
145 AZOTAEMIA 85 0.0213
146 BLOOD CREATINE INCREASED 93 0.0210
147 CATHETERISATION CARDIAC 93 0.0210
148 GENERALISED OEDEMA 258 0.0208
149 CARDIAC VALVE DISEASE 119 0.0208
150 PLEURAL EFFUSION 1260 0.0207
151 UPPER GASTROINTESTINAL HAEMORRHAGE 346 0.0205
152 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1072 0.0205
153 HYPERURICAEMIA 84 0.0204
154 HAEMATOCRIT DECREASED 404 0.0204
155 CARDIOMYOPATHY 301 0.0203
156 OEDEMA PERIPHERAL 2462 0.0202
157 BLOOD POTASSIUM INCREASED 326 0.0201
158 SLEEP APNOEA SYNDROME 382 0.0200
159 MENTAL STATUS CHANGES 548 0.0197
160 HYPONATRAEMIA 1110 0.0197
161 CANDIDIASIS 78 0.0194
162 RENAL TUBULAR NECROSIS 190 0.0194
163 PARAESTHESIA ORAL 279 0.0193
164 HAEMORRHOIDAL HAEMORRHAGE 94 0.0192
165 CHRONIC KIDNEY DISEASE 1448 0.0190
166 EMPHYSEMA 192 0.0190
167 BACTERAEMIA 225 0.0189
168 VAGINAL DISCHARGE 191 0.0189
169 PERICARDIAL EFFUSION 436 0.0188
170 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 72 0.0188
171 COAGULOPATHY 314 0.0188
172 ARTERIOSCLEROSIS 177 0.0188
173 BUNDLE BRANCH BLOCK RIGHT 86 0.0187
174 HOSPICE CARE 184 0.0186
175 FEBRILE NEUTROPENIA 1229 0.0185
176 TRANSFUSION 194 0.0185
177 HIATUS HERNIA 238 0.0184
178 PRODUCT RESIDUE PRESENT 99 0.0183
179 GASTROINTESTINAL HAEMORRHAGE 1531 0.0183
180 DECUBITUS ULCER 149 0.0183
181 SMALL INTESTINAL OBSTRUCTION 225 0.0183
182 SUPRAVENTRICULAR TACHYCARDIA 175 0.0183
183 BACTERIAL INFECTION 341 0.0183
184 DIABETIC NEUROPATHY 90 0.0182
185 ACUTE KIDNEY INJURY 2775 0.0181
186 DYSLIPIDAEMIA 92 0.0181
187 SEPSIS 2015 0.0180
188 PNEUMONIA FUNGAL 71 0.0180
189 DIVERTICULITIS 498 0.0180
190 STAPHYLOCOCCAL BACTERAEMIA 78 0.0179
191 OXYGEN SATURATION DECREASED 1001 0.0178
192 LEUKOCYTOSIS 322 0.0178
193 PURULENT DISCHARGE 76 0.0178
194 ORTHOSTATIC HYPOTENSION 309 0.0177
195 ESCHERICHIA URINARY TRACT INFECTION 75 0.0176
196 DIVERTICULUM INTESTINAL 77 0.0176
197 RESPIRATORY FAILURE 1281 0.0175
198 OEDEMA 952 0.0175
199 SPINAL OSTEOARTHRITIS 153 0.0174
200 TACHYPNOEA 235 0.0173
201 PULMONARY OEDEMA 774 0.0173
202 RENAL CYST 137 0.0172
203 UROSEPSIS 159 0.0172
204 PAIN IN JAW 488 0.0172
205 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 102 0.0172
206 STAPHYLOCOCCAL SEPSIS 85 0.0172
207 OESOPHAGITIS 188 0.0172
208 GASTRITIS EROSIVE 80 0.0171
209 HEPATIC CYTOLYSIS 218 0.0171
210 CELLULITIS 860 0.0170
211 EJECTION FRACTION DECREASED 264 0.0170
212 RECTAL HAEMORRHAGE 727 0.0169
213 MULTIPLE ORGAN DYSFUNCTION SYNDROME 479 0.0169
214 HYDRONEPHROSIS 126 0.0168
215 ACUTE PULMONARY OEDEMA 94 0.0167
216 BRONCHITIS 1239 0.0167
217 MULTIPLE MYELOMA 78 0.0167
218 SHOCK HAEMORRHAGIC 136 0.0167
219 HYPOCALCAEMIA 315 0.0166
220 ANAEMIA 3173 0.0166
221 ENTEROCOCCAL INFECTION 80 0.0165
222 SEPTIC SHOCK 718 0.0165
223 AMMONIA INCREASED 84 0.0164
224 DEHYDRATION 2195 0.0164
225 COMPRESSION FRACTURE 88 0.0164
226 CORONARY ARTERY DISEASE 497 0.0164
227 BLOOD BILIRUBIN INCREASED 443 0.0164
228 BLOOD ALKALINE PHOSPHATASE INCREASED 405 0.0163
229 HYPOVOLAEMIC SHOCK 78 0.0163
230 CARDIAC PACEMAKER INSERTION 97 0.0163
231 CYSTITIS 514 0.0161
232 RENAL FAILURE 2127 0.0160
233 GLAUCOMA 308 0.0160
234 BLOOD CALCIUM INCREASED 140 0.0159
235 CARDIAC FAILURE 1281 0.0159
236 BLOOD SODIUM DECREASED 299 0.0158
237 ECCHYMOSIS 108 0.0157
238 HYPOTENSION 3157 0.0157
239 MULTI-ORGAN FAILURE 271 0.0157
240 URINE OUTPUT DECREASED 137 0.0157
241 SKIN ABRASION 74 0.0156
242 TORSADE DE POINTES 122 0.0155
243 ABDOMINAL TENDERNESS 77 0.0155
244 PROTEIN URINE PRESENT 77 0.0154
245 HYPERCHOLESTEROLAEMIA 149 0.0154
246 SINUS BRADYCARDIA 149 0.0154
247 SKIN LACERATION 167 0.0153
248 HUMERUS FRACTURE 74 0.0153
249 COLITIS 581 0.0153
250 RESPIRATORY DISTRESS 421 0.0152
251 PULMONARY CONGESTION 200 0.0152
252 CORONARY ARTERY STENOSIS 76 0.0151
253 ILEUS 187 0.0150
254 CHOLECYSTITIS ACUTE 85 0.0150
255 PRODUCTIVE COUGH 715 0.0150
256 PANCYTOPENIA 835 0.0149
257 LYMPHOCYTE COUNT DECREASED 264 0.0149
258 INTERVERTEBRAL DISC DEGENERATION 138 0.0149
259 ULCER 236 0.0148
260 FAECAL INCONTINENCE 71 0.0148
261 COVID-19 PNEUMONIA 174 0.0147
262 SINUS TACHYCARDIA 209 0.0147
263 INTESTINAL ISCHAEMIA 81 0.0147
264 NEUTROPENIC SEPSIS 105 0.0147
265 GASTROOESOPHAGEAL REFLUX DISEASE 1183 0.0147
266 BLOOD CREATININE INCREASED 957 0.0146
267 HAEMOPTYSIS 408 0.0146
268 TUMOUR LYSIS SYNDROME 128 0.0145
269 DEVICE RELATED INFECTION 223 0.0145
270 BODY HEIGHT DECREASED 154 0.0144
271 PULMONARY MASS 214 0.0144
272 ADRENAL INSUFFICIENCY 174 0.0143
273 DIZZINESS POSTURAL 139 0.0143
274 ENCEPHALOPATHY 352 0.0143
275 BLOOD CALCIUM DECREASED 161 0.0143
276 HAEMORRHOIDS 279 0.0143
277 SPUTUM DISCOLOURED 135 0.0142
278 SCOLIOSIS 88 0.0142
279 ESCHERICHIA INFECTION 116 0.0141
280 OBESITY 224 0.0140
281 EXTRASYSTOLES 98 0.0140
282 RENAL INJURY 417 0.0140
283 PNEUMONIA 4543 0.0140
284 ASPIRATION 153 0.0140
285 EPISTAXIS 1043 0.0139
286 HYPERCALCAEMIA 172 0.0139
287 MELAENA 306 0.0139
288 FULL BLOOD COUNT DECREASED 280 0.0139
289 HEPATIC ENCEPHALOPATHY 129 0.0138
290 CACHEXIA 71 0.0138
291 HEART RATE IRREGULAR 311 0.0137
292 VITAMIN D DEFICIENCY 134 0.0137
293 SUBDURAL HAEMATOMA 196 0.0137
294 PNEUMONIA BACTERIAL 125 0.0136
295 ATRIOVENTRICULAR BLOCK COMPLETE 91 0.0136
296 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 232 0.0135
297 HAEMOGLOBIN DECREASED 1388 0.0135
298 HAEMODIALYSIS 113 0.0134
299 C-REACTIVE PROTEIN INCREASED 489 0.0134
300 HAEMATOMA 347 0.0134
301 UPPER RESPIRATORY TRACT INFECTION 618 0.0134
302 BRADYCARDIA 707 0.0133
303 POLYURIA 109 0.0133
304 PSEUDOMONAS INFECTION 113 0.0132
305 HYPERBILIRUBINAEMIA 136 0.0131
306 INTERNAL HAEMORRHAGE 150 0.0131
307 ANHEDONIA 344 0.0131
308 BLOOD IRON DECREASED 155 0.0130
309 FULL BLOOD COUNT ABNORMAL 138 0.0130
310 CARDIAC ARREST 1074 0.0130
311 RED BLOOD CELL COUNT DECREASED 371 0.0130
312 NEURALGIA 314 0.0129
313 WEIGHT FLUCTUATION 134 0.0128
314 ATRIOVENTRICULAR BLOCK 99 0.0128
315 NEUTROPHIL COUNT INCREASED 131 0.0128
316 CHOLECYSTITIS 152 0.0127
317 GASTROENTERITIS 186 0.0127
318 TRANSIENT ISCHAEMIC ATTACK 430 0.0127
319 UPPER-AIRWAY COUGH SYNDROME 105 0.0127
320 HEART RATE ABNORMAL 71 0.0127
321 CHOLELITHIASIS 414 0.0126
322 REFUSAL OF TREATMENT BY PATIENT 82 0.0125
323 CARDIAC FLUTTER 81 0.0125
324 BLOOD TEST ABNORMAL 176 0.0125
325 PLATELET COUNT DECREASED 1334 0.0125
326 UNRESPONSIVE TO STIMULI 323 0.0125
327 ASPARTATE AMINOTRANSFERASE INCREASED 663 0.0125
328 CATARACT OPERATION 74 0.0125
329 SYNOVITIS 224 0.0124
330 HAEMORRHAGIC STROKE 97 0.0124
331 PRESYNCOPE 301 0.0124
332 GLOMERULAR FILTRATION RATE DECREASED 152 0.0124
333 COMA 588 0.0123
334 URINARY TRACT INFECTION 2103 0.0123
335 ACUTE MYOCARDIAL INFARCTION 363 0.0123
336 ANGINA UNSTABLE 80 0.0123
337 MYOCARDIAL ISCHAEMIA 140 0.0123
338 SPINAL COMPRESSION FRACTURE 101 0.0122
339 HYPERGLYCAEMIA 445 0.0122
340 RESPIRATORY TRACT CONGESTION 194 0.0122
341 INCREASED TENDENCY TO BRUISE 112 0.0122
342 STAPHYLOCOCCAL INFECTION 400 0.0121
343 PYELONEPHRITIS 105 0.0121
344 PROCEDURAL PAIN 336 0.0121
345 FREQUENT BOWEL MOVEMENTS 327 0.0121
346 CLOSTRIDIUM DIFFICILE INFECTION 264 0.0121
347 DYSPNOEA 6837 0.0121
348 FIBROMYALGIA 293 0.0120
349 CONSTIPATION 2622 0.0120
350 COLITIS ISCHAEMIC 81 0.0120
351 HEAD INJURY 379 0.0120
352 BLOOD PRESSURE DECREASED 792 0.0119
353 BRONCHIECTASIS 80 0.0119
354 ABDOMINAL DISTENSION 1234 0.0118
355 THROMBOCYTOPENIA 1322 0.0118
356 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
357 LUNG INFECTION 182 0.0117
358 RESPIRATORY SYNCYTIAL VIRUS INFECTION 102 0.0117
359 SINUS DISORDER 231 0.0117
360 ELECTROCARDIOGRAM QT PROLONGED 419 0.0116
361 THYROID DISORDER 179 0.0116
362 NERVE COMPRESSION 107 0.0116
363 DEEP VEIN THROMBOSIS 753 0.0116
364 DEMENTIA 322 0.0115
365 PETECHIAE 120 0.0115
366 SYNCOPE 1148 0.0115
367 CANDIDA INFECTION 193 0.0114
368 TENDERNESS 119 0.0114
369 NEPHROPATHY 106 0.0113
370 MYOPATHY 98 0.0113
371 HEPATIC CIRRHOSIS 213 0.0113
372 SINUS CONGESTION 153 0.0113
373 MOUTH HAEMORRHAGE 83 0.0113
374 RESPIRATORY RATE INCREASED 100 0.0113
375 LOCALISED INFECTION 272 0.0112
376 PSYCHOLOGICAL TRAUMA 97 0.0112
377 SCIATICA 179 0.0112
378 WALKING AID USER 74 0.0112
379 PULMONARY THROMBOSIS 122 0.0112
380 DIABETES MELLITUS INADEQUATE CONTROL 198 0.0112
381 SPLENOMEGALY 131 0.0112
382 PARKINSONISM 109 0.0112
383 ASTHENIA 4203 0.0112
384 ARRHYTHMIA 527 0.0111
385 LARGE INTESTINE POLYP 77 0.0111
386 WHITE BLOOD CELL COUNT INCREASED 426 0.0111
387 TASTE DISORDER 225 0.0111
388 DEVICE OCCLUSION 156 0.0111
389 IMPAIRED GASTRIC EMPTYING 151 0.0111
390 FALL 3686 0.0111
391 NEUTROPHIL COUNT DECREASED 451 0.0111
392 PERIPHERAL SWELLING 1697 0.0110
393 PULMONARY HAEMORRHAGE 86 0.0110
394 WOUND INFECTION 120 0.0109
395 GASTRITIS 288 0.0109
396 HAEMATURIA 374 0.0109
397 CIRCULATORY COLLAPSE 186 0.0109
398 ACUTE RESPIRATORY DISTRESS SYNDROME 193 0.0109
399 HEPATOMEGALY 107 0.0109
400 TUBULOINTERSTITIAL NEPHRITIS 204 0.0109
401 HYPOPHAGIA 278 0.0109
402 MICTURITION URGENCY 124 0.0108
403 LACERATION 102 0.0108
404 POLYP 71 0.0108
405 HYPOGLYCAEMIA 525 0.0108
406 CHEST PAIN 2002 0.0108
407 GASTRIC ULCER 205 0.0108
408 LABORATORY TEST ABNORMAL 318 0.0108
409 WRIST FRACTURE 129 0.0108
410 WEIGHT DECREASED 2991 0.0107
411 HAEMATOCHEZIA 591 0.0107
412 BLOOD PRESSURE DIASTOLIC DECREASED 79 0.0107
413 PULMONARY EMBOLISM 1017 0.0107
414 FLANK PAIN 100 0.0107
415 DIARRHOEA 6881 0.0106
416 PELVIC FRACTURE 83 0.0106
417 ABDOMINAL PAIN 2476 0.0106
418 ALANINE AMINOTRANSFERASE INCREASED 653 0.0106
419 HEPATIC STEATOSIS 198 0.0106
420 SUBARACHNOID HAEMORRHAGE 108 0.0106
421 RIB FRACTURE 218 0.0106
422 NEUROPATHY PERIPHERAL 1007 0.0106
423 JOINT INJURY 226 0.0106
424 CORONARY ARTERY OCCLUSION 145 0.0106
425 HYPOTHYROIDISM 336 0.0105
426 AORTIC ANEURYSM 80 0.0105
427 OSTEOARTHRITIS 444 0.0105
428 NOCTURIA 127 0.0105
429 DISSEMINATED INTRAVASCULAR COAGULATION 147 0.0104
430 CARDIO-RESPIRATORY ARREST 436 0.0104
431 TACHYCARDIA 925 0.0104
432 WHITE BLOOD CELL COUNT DECREASED 1127 0.0104
433 BLOOD PRESSURE ABNORMAL 206 0.0104
434 PNEUMONITIS 282 0.0103
435 COUGH 2895 0.0103
436 INCONTINENCE 109 0.0103
437 DECREASED APPETITE 2393 0.0103
438 JOINT EFFUSION 71 0.0103
439 MUSCULOSKELETAL CHEST PAIN 159 0.0103
440 THROMBOSIS 823 0.0102
441 CONTUSION 981 0.0102
442 CYANOSIS 160 0.0102
443 DYSURIA 374 0.0102
444 POST PROCEDURAL COMPLICATION 195 0.0101
445 PLASMA CELL MYELOMA 395 0.0101
446 HAEMODYNAMIC INSTABILITY 77 0.0101
447 ACIDOSIS 77 0.0101
448 ACUTE MYELOID LEUKAEMIA 157 0.0101
449 OSTEOPOROSIS 414 0.0101
450 GENERAL PHYSICAL HEALTH DETERIORATION 1164 0.0101
451 RESPIRATORY TRACT INFECTION 262 0.0100
452 PNEUMOTHORAX 159 0.0100
453 SKIN REACTION 141 0.0100
454 MOTOR DYSFUNCTION 102 0.0100
455 SKIN ULCER 258 0.0100
456 GASTROENTERITIS VIRAL 180 0.0100
457 NASAL CONGESTION 585 0.0099
458 HYPERTHYROIDISM 144 0.0099
459 ANOREXIA 128 0.0099
460 LIGAMENT SPRAIN 98 0.0099
461 INTERVERTEBRAL DISC PROTRUSION 216 0.0099
462 EMBOLISM 82 0.0099
463 KIDNEY INFECTION 193 0.0098
464 PURPURA 87 0.0098
465 HAEMOLYTIC ANAEMIA 88 0.0098
466 OSTEOPENIA 149 0.0098
467 LUNG DISORDER 481 0.0098
468 BLOOD PRESSURE SYSTOLIC INCREASED 191 0.0098
469 BOWEL MOVEMENT IRREGULARITY 75 0.0098
470 GROIN PAIN 86 0.0098
471 HERNIA 189 0.0098
472 AGRANULOCYTOSIS 181 0.0097
473 POST PROCEDURAL HAEMORRHAGE 113 0.0097
474 HAEMORRHAGE INTRACRANIAL 145 0.0097
475 URINARY RETENTION 323 0.0097
476 ANAL INCONTINENCE 87 0.0097
477 GAMMA-GLUTAMYLTRANSFERASE INCREASED 214 0.0096
478 RETCHING 205 0.0096
479 RESTLESS LEGS SYNDROME 174 0.0096
480 HYPERTHERMIA 73 0.0096
481 OSTEOMYELITIS 173 0.0095
482 URINARY INCONTINENCE 282 0.0095
483 STOMATITIS 575 0.0095
484 FAECES DISCOLOURED 205 0.0094
485 BLOOD THYROID STIMULATING HORMONE INCREASED 87 0.0094
486 METABOLIC ACIDOSIS 302 0.0094
487 DYSPEPSIA 928 0.0094
488 HEPATIC FAILURE 284 0.0094
489 WHEEZING 558 0.0094
490 CHEST DISCOMFORT 961 0.0094
491 CHOLESTASIS 180 0.0094
492 BLOOD DISORDER 75 0.0094
493 INITIAL INSOMNIA 96 0.0093
494 LIMB INJURY 254 0.0093
495 SINUSITIS 958 0.0093
496 HEART RATE DECREASED 328 0.0093
497 TOOTH ABSCESS 95 0.0093
498 BACK PAIN 2165 0.0093
499 SHOCK 214 0.0093
500 PANCREATITIS ACUTE 209 0.0093
501 GINGIVAL PAIN 74 0.0093
502 DECREASED ACTIVITY 100 0.0093
503 DRUG INTERACTION 1467 0.0092
504 HIP FRACTURE 297 0.0092
505 OROPHARYNGEAL DISCOMFORT 83 0.0092
506 LOW BIRTH WEIGHT BABY 73 0.0092
507 CONFUSIONAL STATE 1478 0.0091
508 HEREDITARY ANGIOEDEMA 98 0.0091
509 RENAL IMPAIRMENT 767 0.0091
510 MUCOSAL INFLAMMATION 239 0.0091
511 RASH MACULO-PAPULAR 203 0.0091
512 PYREXIA 3157 0.0091
513 ORAL PAIN 204 0.0091
514 LACTIC ACIDOSIS 295 0.0091
515 ATAXIA 108 0.0091
516 HYPERTENSION 1923 0.0091
517 ACUTE CORONARY SYNDROME 75 0.0090
518 STENT PLACEMENT 73 0.0090
519 HALLUCINATION 682 0.0090
520 ANKLE FRACTURE 140 0.0090
521 DIABETES MELLITUS 689 0.0090
522 GASTROINTESTINAL INFECTION 81 0.0090
523 BLOOD LACTATE DEHYDROGENASE INCREASED 143 0.0090
524 INJURY 634 0.0090
525 PERITONITIS BACTERIAL 91 0.0090
526 THERAPY NON-RESPONDER 405 0.0090
527 GALLBLADDER DISORDER 160 0.0090
528 VOMITING 4213 0.0090
529 DRY MOUTH 723 0.0089
530 BURSITIS 108 0.0089
531 HEART RATE INCREASED 880 0.0089
532 BLOOD CHOLESTEROL INCREASED 414 0.0089
533 SECRETION DISCHARGE 111 0.0089
534 HAIR DISORDER 73 0.0089
535 BLOOD URINE PRESENT 168 0.0088
536 FACIAL PAIN 79 0.0088
537 ABSCESS 141 0.0088
538 SKIN INFECTION 99 0.0088
539 NEUTROPENIA 1196 0.0088
540 NECK PAIN 491 0.0088
541 SWELLING 822 0.0088
542 FEEDING DISORDER 178 0.0088
543 BONE MARROW FAILURE 178 0.0088
544 CARDIAC DISORDER 819 0.0087
545 TOXIC SKIN ERUPTION 88 0.0087
546 LETHARGY 502 0.0087
547 HYPERSOMNIA 250 0.0087
548 THROAT IRRITATION 391 0.0087
549 INFUSION RELATED REACTION 577 0.0087
550 MUSCULOSKELETAL PAIN 455 0.0087
551 BLADDER DISORDER 86 0.0087
552 BLOOD COUNT ABNORMAL 131 0.0086
553 PRODUCT DISTRIBUTION ISSUE 80 0.0086
554 LIVER FUNCTION TEST ABNORMAL 250 0.0086
555 FEAR 231 0.0086
556 MUSCULAR WEAKNESS 970 0.0085
557 INSURANCE ISSUE 130 0.0085
558 HEMIPARESIS 144 0.0085
559 DENTAL CARIES 94 0.0085
560 LIVER FUNCTION TEST INCREASED 182 0.0085
561 BEDRIDDEN 111 0.0084
562 HAEMATEMESIS 214 0.0084
563 PALPITATIONS 987 0.0084
564 MUSCULOSKELETAL DISCOMFORT 145 0.0084
565 GINGIVAL BLEEDING 115 0.0084
566 UNEVALUABLE EVENT 637 0.0084
567 STEVENS-JOHNSON SYNDROME 187 0.0084
568 TRANSAMINASES INCREASED 187 0.0084
569 ROTATOR CUFF SYNDROME 108 0.0084
570 MOUTH ULCERATION 177 0.0084
571 IMMUNODEFICIENCY 125 0.0084
572 NAUSEA 6625 0.0084
573 ANURIA 72 0.0084
574 DELIRIUM 290 0.0083
575 VIRAL INFECTION 277 0.0083
576 EXOSTOSIS 76 0.0083
577 SOMNOLENCE 1672 0.0083
578 BACK DISORDER 135 0.0083
579 EAR DISCOMFORT 85 0.0083
580 IMPAIRED QUALITY OF LIFE 119 0.0083
581 CYTOPENIA 101 0.0082
582 DYSPHONIA 482 0.0082
583 RENAL DISORDER 384 0.0082
584 FATIGUE 6409 0.0082
585 MASS 115 0.0082
586 RED BLOOD CELL SEDIMENTATION RATE INCREASED 91 0.0082
587 FUNGAL INFECTION 274 0.0082
588 FOOT FRACTURE 155 0.0082
589 DISEASE PROGRESSION 967 0.0082
590 CHILLS 956 0.0081
591 FLUSHING 829 0.0081
592 BRAIN OEDEMA 103 0.0081
593 DYSPHAGIA 772 0.0081
594 PULMONARY FIBROSIS 156 0.0081
595 PRODUCT USE COMPLAINT 128 0.0081
596 INTESTINAL OBSTRUCTION 306 0.0081
597 CATARACT 483 0.0081
598 DIZZINESS 4045 0.0081
599 BALANCE DISORDER 701 0.0081
600 DYSARTHRIA 305 0.0081
601 TYPE 2 DIABETES MELLITUS 272 0.0081
602 DRUG TOXICITY 110 0.0081
603 SQUAMOUS CELL CARCINOMA 76 0.0081
604 NEPHROLITHIASIS 370 0.0081
605 NERVE INJURY 89 0.0080
606 ANGINA PECTORIS 229 0.0080
607 RESPIRATORY ARREST 220 0.0080
608 EAR PAIN 155 0.0080
609 EYE INFECTION 90 0.0080
610 DIALYSIS 113 0.0080
611 HAIR COLOUR CHANGES 99 0.0079
612 BODY TEMPERATURE INCREASED 162 0.0079
613 BLOOD TRIGLYCERIDES INCREASED 140 0.0079
614 CEREBRAL HAEMORRHAGE 283 0.0079
615 APHASIA 238 0.0079
616 POLLAKIURIA 328 0.0079
617 FLATULENCE 445 0.0078
618 PAIN IN EXTREMITY 2309 0.0078
619 BONE DISORDER 142 0.0078
620 NO THERAPEUTIC RESPONSE 95 0.0078
621 SPINAL FRACTURE 156 0.0078
622 COMPLICATION ASSOCIATED WITH DEVICE 112 0.0077
623 RHABDOMYOLYSIS 321 0.0077
624 JAUNDICE 207 0.0077
625 RESPIRATORY DISORDER 230 0.0077
626 ISCHAEMIC STROKE 137 0.0077
627 INFLUENZA 856 0.0077
628 BLOOD PRESSURE INCREASED 1171 0.0077
629 FEELING COLD 213 0.0076
630 CARPAL TUNNEL SYNDROME 107 0.0076
631 HYPOTONIA 76 0.0076
632 WEIGHT INCREASED 1702 0.0076
633 EAR INFECTION 202 0.0076
634 UPPER LIMB FRACTURE 151 0.0076
635 HYPOKINESIA 110 0.0076
636 ILLNESS 780 0.0076
637 JOINT DISLOCATION 80 0.0076
638 HERPES ZOSTER 434 0.0075
639 MYELODYSPLASTIC SYNDROME 109 0.0075
640 TINNITUS 346 0.0075
641 ABASIA 186 0.0075
642 DRUG INTOLERANCE 727 0.0075
643 TOOTH INFECTION 99 0.0075
644 AGEUSIA 187 0.0075
645 BLOOD PRESSURE FLUCTUATION 179 0.0074
646 ARTHRITIS 586 0.0074
647 COLD SWEAT 131 0.0074
648 DISORIENTATION 294 0.0074
649 HAIR TEXTURE ABNORMAL 99 0.0074
650 MUSCLE SPASMS 1353 0.0074
651 TOOTH FRACTURE 81 0.0073
652 LEUKOPENIA 366 0.0073
653 SLEEP DISORDER 516 0.0073
654 BLISTER 409 0.0073
655 SUDDEN DEATH 77 0.0073
656 BRAIN FOG 114 0.0073
657 INTERSTITIAL LUNG DISEASE 352 0.0073
658 MYOCARDIAL INFARCTION 1268 0.0073
659 PROSTATIC SPECIFIC ANTIGEN INCREASED 100 0.0073
660 RHINORRHOEA 469 0.0072
661 INFECTION 1050 0.0072
662 HYPERHIDROSIS 927 0.0072
663 ABDOMINAL PAIN UPPER 1481 0.0072
664 EOSINOPHILIA 126 0.0072
665 LOSS OF CONSCIOUSNESS 921 0.0072
666 TEMPERATURE INTOLERANCE 74 0.0072
667 DRUG LEVEL INCREASED 118 0.0071
668 DYSSTASIA 208 0.0071
669 TREATMENT NONCOMPLIANCE 389 0.0071
670 GASTROINTESTINAL DISORDER 635 0.0071
671 PRODUCT ADMINISTRATION ERROR 143 0.0071
672 SKIN DISCOLOURATION 324 0.0070
673 PERITONITIS 146 0.0070
674 EATING DISORDER 150 0.0070
675 DEPRESSION 1602 0.0070
676 GASTRIC HAEMORRHAGE 81 0.0070
677 SKIN LESION 193 0.0070
678 DEVICE FAILURE 107 0.0070
679 OROPHARYNGEAL PAIN 650 0.0070
680 PALLOR 191 0.0070
681 HYPOTHERMIA 71 0.0070
682 TREMOR 1160 0.0070
683 BONE PAIN 409 0.0070
684 INJECTION SITE EXTRAVASATION 86 0.0070
685 TOOTHACHE 126 0.0070
686 GAIT DISTURBANCE 1331 0.0069
687 BRONCHOSPASM 99 0.0069
688 LYMPHOPENIA 98 0.0069
689 ACTIVITIES OF DAILY LIVING IMPAIRED 136 0.0069
690 AGITATION 504 0.0069
691 CONJUNCTIVITIS 127 0.0068
692 BLOOD GLUCOSE FLUCTUATION 75 0.0068
693 EYE DISCHARGE 71 0.0068
694 HEADACHE 4283 0.0068
695 BLOOD GLUCOSE DECREASED 328 0.0068
696 ANXIETY 1942 0.0068
697 HALLUCINATION, VISUAL 144 0.0068
698 STATUS EPILEPTICUS 77 0.0068
699 ABDOMINAL DISCOMFORT 1139 0.0068
700 LACRIMATION INCREASED 205 0.0068
701 CONDITION AGGRAVATED 2051 0.0067
702 METASTASES TO CENTRAL NERVOUS SYSTEM 87 0.0067
703 MALAISE 2941 0.0067
704 INTESTINAL PERFORATION 75 0.0067
705 DEPRESSED LEVEL OF CONSCIOUSNESS 264 0.0067
706 TOOTH DISORDER 148 0.0066
707 OBSTRUCTIVE AIRWAYS DISORDER 74 0.0066
708 MUSCLE ATROPHY 84 0.0066
709 MOBILITY DECREASED 476 0.0066
710 AMNESIA 431 0.0066
711 CEREBROVASCULAR ACCIDENT 1122 0.0066
712 HAEMORRHAGE 692 0.0066
713 SCAR 113 0.0066
714 METASTASES TO LIVER 116 0.0066
715 PLATELET COUNT INCREASED 86 0.0066
716 TOOTH EXTRACTION 82 0.0066
717 COLON CANCER 98 0.0066
718 PROTEINURIA 125 0.0066
719 LOWER LIMB FRACTURE 126 0.0066
720 ASTHMA 740 0.0065
721 LIVER DISORDER 290 0.0065
722 COVID-19 1143 0.0065
723 CEREBRAL INFARCTION 159 0.0065
724 FEMUR FRACTURE 201 0.0065
725 EYE PAIN 366 0.0065
726 CHOLECYSTECTOMY 74 0.0065
727 MIGRAINE 618 0.0065
728 PANCREATITIS 342 0.0065
729 DIPLOPIA 168 0.0065
730 MYOCLONUS 77 0.0064
731 JOINT SWELLING 778 0.0064
732 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 309 0.0064
733 HEPATIC ENZYME INCREASED 438 0.0064
734 HYPOAESTHESIA 961 0.0064
735 OCULAR DISCOMFORT 72 0.0064
736 NIGHT SWEATS 206 0.0064
737 PAIN 3918 0.0064
738 WOUND 178 0.0064
739 MUSCLE RIGIDITY 76 0.0063
740 SKIN HAEMORRHAGE 94 0.0063
741 LIMB DISCOMFORT 196 0.0063
742 LYMPHADENOPATHY 224 0.0063
743 FEELING ABNORMAL 1513 0.0063
744 SNEEZING 141 0.0063
745 THERAPY PARTIAL RESPONDER 98 0.0063
746 NEUROTOXICITY 110 0.0063
747 COLITIS ULCERATIVE 280 0.0063
748 SPINAL OPERATION 77 0.0062
749 CONTRAINDICATED PRODUCT ADMINISTERED 189 0.0062
750 BLOOD GLUCOSE INCREASED 1176 0.0062
751 COMPLETED SUICIDE 516 0.0062
752 PERIPHERAL COLDNESS 85 0.0062
753 NEOPLASM 71 0.0062
754 PHOTOPHOBIA 115 0.0061
755 MULTIPLE FRACTURES 100 0.0061
756 IMMUNE SYSTEM DISORDER 80 0.0061
757 RASH PRURITIC 328 0.0060
758 JOINT RANGE OF MOTION DECREASED 81 0.0060
759 NASOPHARYNGITIS 1112 0.0060
760 MEDICATION ERROR 335 0.0060
761 BASAL CELL CARCINOMA 94 0.0060
762 LOCAL SWELLING 105 0.0060
763 INSOMNIA 1599 0.0060
764 VISION BLURRED 822 0.0060
765 CHOKING 116 0.0059
766 POOR QUALITY SLEEP 128 0.0059
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 171 0.0059
768 THIRST 106 0.0059
769 GAIT INABILITY 198 0.0059
770 GASTRIC DISORDER 203 0.0059
771 NODULE 77 0.0059
772 PHARMACEUTICAL PRODUCT COMPLAINT 153 0.0059
773 MEMORY IMPAIRMENT 809 0.0059
774 SPEECH DISORDER 307 0.0059
775 ARTHRALGIA 2433 0.0058
776 CONVULSION 334 0.0058
777 ERUCTATION 113 0.0058
778 RESTLESSNESS 212 0.0058
779 CARDIOVASCULAR DISORDER 147 0.0058
780 COGNITIVE DISORDER 270 0.0058
781 MYALGIA 983 0.0058
782 SWELLING FACE 375 0.0058
783 MALIGNANT NEOPLASM PROGRESSION 589 0.0057
784 PRESCRIBED UNDERDOSE 114 0.0057
785 ARTHROPATHY 317 0.0057
786 ERYTHEMA 1169 0.0057
787 HOT FLUSH 427 0.0057
788 IMPAIRED HEALING 186 0.0057
789 DELUSION 88 0.0057
790 KNEE ARTHROPLASTY 119 0.0056
791 PRODUCT DOSE OMISSION IN ERROR 160 0.0056
792 HEAD DISCOMFORT 100 0.0056
793 NERVOUSNESS 295 0.0056
794 HYPOACUSIS 243 0.0056
795 MUSCLE TIGHTNESS 91 0.0056
796 VERTIGO 342 0.0056
797 APHONIA 78 0.0056
798 HEPATIC FUNCTION ABNORMAL 208 0.0056
799 PREMATURE BABY 167 0.0055
800 FEELING HOT 340 0.0055
801 INTENTIONAL DOSE OMISSION 158 0.0055
802 ALTERED STATE OF CONSCIOUSNESS 120 0.0055
803 ROAD TRAFFIC ACCIDENT 230 0.0055
804 LOWER RESPIRATORY TRACT INFECTION 249 0.0055
805 RASH MACULAR 191 0.0055
806 RASH ERYTHEMATOUS 259 0.0054
807 DEATH 4664 0.0054
808 EYE DISORDER 178 0.0054
809 FEELING JITTERY 103 0.0054
810 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 384 0.0054
811 PARALYSIS 77 0.0054
812 CYTOMEGALOVIRUS INFECTION 89 0.0053
813 HIP ARTHROPLASTY 82 0.0053
814 INCREASED APPETITE 102 0.0053
815 PRODUCT DOSE OMISSION ISSUE 1568 0.0053
816 IRRITABLE BOWEL SYNDROME 114 0.0053
817 ACCIDENTAL OVERDOSE 194 0.0053
818 PARAESTHESIA 832 0.0053
819 METASTASES TO BONE 86 0.0052
820 PRURITUS GENERALISED 113 0.0052
821 DYSGEUSIA 388 0.0052
822 THERAPY INTERRUPTED 373 0.0052
823 SWOLLEN TONGUE 163 0.0052
824 EYE SWELLING 194 0.0052
825 HOSPITALISATION 801 0.0052
826 OSTEONECROSIS OF JAW 129 0.0052
827 PRODUCT DOSE OMISSION 340 0.0052
828 DEAFNESS 136 0.0052
829 COORDINATION ABNORMAL 72 0.0052
830 MIDDLE INSOMNIA 96 0.0051
831 CHROMATURIA 116 0.0051
832 MUSCLE TWITCHING 118 0.0051
833 NERVOUS SYSTEM DISORDER 158 0.0051
834 PRODUCT PRESCRIBING ERROR 120 0.0050
835 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 116 0.0050
836 SKIN FISSURES 97 0.0050
837 RASH 2162 0.0050
838 PRURITUS 1902 0.0049
839 PERICARDITIS 83 0.0049
840 MUSCULOSKELETAL STIFFNESS 431 0.0049
841 GLYCOSYLATED HAEMOGLOBIN INCREASED 124 0.0049
842 ALOPECIA 961 0.0049
843 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 83 0.0049
844 INTENTIONAL PRODUCT MISUSE 427 0.0049
845 BURNING SENSATION 340 0.0048
846 DRUG-INDUCED LIVER INJURY 151 0.0048
847 VISUAL IMPAIRMENT 595 0.0048
848 DIABETIC KETOACIDOSIS 115 0.0048
849 ABDOMINAL PAIN LOWER 121 0.0048
850 HYPOAESTHESIA ORAL 72 0.0048
851 SKIN DISORDER 159 0.0048
852 LIVER INJURY 117 0.0048
853 GENERALISED TONIC-CLONIC SEIZURE 78 0.0047
854 ILL-DEFINED DISORDER 286 0.0047
855 OFF LABEL USE 4119 0.0047
856 THINKING ABNORMAL 87 0.0047
857 OCULAR HYPERAEMIA 221 0.0047
858 BLOOD GLUCOSE ABNORMAL 86 0.0047
859 SURGERY 272 0.0046
860 BLINDNESS 189 0.0046
861 DRY EYE 231 0.0046
862 RASH PAPULAR 103 0.0046
863 HEPATITIS 117 0.0046
864 ANAPHYLACTIC REACTION 252 0.0046
865 SEIZURE 525 0.0045
866 NEOPLASM PROGRESSION 158 0.0045
867 LIP SWELLING 151 0.0045
868 THROAT TIGHTNESS 122 0.0045
869 SENSORY DISTURBANCE 72 0.0045
870 DYSKINESIA 182 0.0045
871 INFLAMMATION 231 0.0045
872 JOINT STIFFNESS 117 0.0045
873 PREMATURE DELIVERY 71 0.0045
874 DERMATITIS 93 0.0044
875 DEVICE DISLOCATION 192 0.0044
876 SKIN CANCER 95 0.0044
877 PRODUCT USE ISSUE 829 0.0044
878 RASH GENERALISED 114 0.0044
879 EMOTIONAL DISTRESS 531 0.0044
880 PANIC ATTACK 159 0.0044
881 EYE IRRITATION 251 0.0044
882 VISUAL ACUITY REDUCED 144 0.0043
883 INTENTIONAL PRODUCT USE ISSUE 378 0.0043
884 MENTAL IMPAIRMENT 104 0.0043
885 SKIN EXFOLIATION 361 0.0043
886 MENTAL DISORDER 186 0.0043
887 EMOTIONAL DISORDER 131 0.0042
888 SEDATION 111 0.0042
889 DISCOMFORT 256 0.0042
890 MYELOSUPPRESSION 151 0.0042
891 INFLUENZA LIKE ILLNESS 343 0.0042
892 EYE PRURITUS 137 0.0041
893 MUSCULOSKELETAL DISORDER 77 0.0040
894 DEVICE LEAKAGE 175 0.0040
895 PRODUCT USE IN UNAPPROVED INDICATION 999 0.0040
896 DISTURBANCE IN ATTENTION 216 0.0040
897 DRY SKIN 534 0.0040
898 RHEUMATOID ARTHRITIS 454 0.0040
899 ORAL HERPES 78 0.0040
900 HYPERSENSITIVITY 740 0.0040
901 GLOSSODYNIA 89 0.0040
902 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 712 0.0039
903 THERAPEUTIC RESPONSE UNEXPECTED 177 0.0039
904 MOVEMENT DISORDER 125 0.0039
905 TOXICITY TO VARIOUS AGENTS 654 0.0039
906 URTICARIA 637 0.0038
907 SYSTEMIC LUPUS ERYTHEMATOSUS 134 0.0038
908 WRONG TECHNIQUE IN DRUG USAGE PROCESS 137 0.0038
909 DEPRESSED MOOD 199 0.0038
910 TOOTH LOSS 78 0.0038
911 FRACTURE 71 0.0037
912 ADVERSE DRUG REACTION 336 0.0037
913 THERAPY CESSATION 192 0.0037
914 NIGHTMARE 129 0.0037
915 PSYCHOTIC DISORDER 110 0.0037
916 LUNG NEOPLASM MALIGNANT 153 0.0037
917 ABNORMAL DREAMS 102 0.0037
918 NEOPLASM MALIGNANT 245 0.0037
919 HEPATOTOXICITY 81 0.0036
920 OSTEONECROSIS 119 0.0036
921 ECZEMA 187 0.0036
922 PRODUCT PREPARATION ERROR 73 0.0035
923 IMPAIRED WORK ABILITY 75 0.0035
924 TREATMENT FAILURE 290 0.0035
925 ANGIOEDEMA 152 0.0034
926 ERECTILE DYSFUNCTION 88 0.0034
927 ADVERSE EVENT 312 0.0034
928 PAIN OF SKIN 91 0.0034
929 THERAPEUTIC RESPONSE DECREASED 204 0.0034
930 VAGINAL HAEMORRHAGE 146 0.0034
931 DISEASE RECURRENCE 160 0.0034
932 UNDERDOSE 244 0.0033
933 CRYING 121 0.0033
934 BONE DENSITY DECREASED 104 0.0033
935 THERAPEUTIC PRODUCT EFFECT DECREASED 148 0.0033
936 PSORIATIC ARTHROPATHY 133 0.0033
937 DRUG ADMINISTRATION ERROR 100 0.0033
938 ABNORMAL BEHAVIOUR 128 0.0032
939 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 82 0.0032
940 INTENTIONAL OVERDOSE 204 0.0032
941 ANAPHYLACTIC SHOCK 81 0.0031
942 DEVICE MALFUNCTION 220 0.0031
943 PRODUCT AVAILABILITY ISSUE 71 0.0031
944 IRRITABILITY 183 0.0030
945 DRUG DOSE OMISSION 499 0.0030
946 DEVICE ISSUE 265 0.0030
947 MOOD ALTERED 80 0.0029
948 INCORRECT DOSE ADMINISTERED 658 0.0029
949 AGGRESSION 144 0.0029
950 NEEDLE ISSUE 82 0.0028
951 OVERDOSE 602 0.0028
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 198 0.0028
953 DRUG INEFFECTIVE 3638 0.0028
954 MULTIPLE SCLEROSIS 131 0.0027
955 INJECTION SITE PRURITUS 182 0.0027
956 DEVICE USE ERROR 94 0.0027
957 MATERNAL EXPOSURE DURING PREGNANCY 238 0.0027
958 MULTIPLE SCLEROSIS RELAPSE 183 0.0027
959 PANCREATIC CARCINOMA 74 0.0026
960 DRUG EFFECT DECREASED 138 0.0026
961 EPILEPSY 76 0.0025
962 INJECTION SITE ERYTHEMA 304 0.0024
963 INJECTION SITE RASH 74 0.0024
964 EXTRA DOSE ADMINISTERED 97 0.0024
965 INJECTION SITE MASS 88 0.0024
966 INJECTION SITE HAEMORRHAGE 188 0.0024
967 SUICIDE ATTEMPT 141 0.0023
968 FOETAL EXPOSURE DURING PREGNANCY 187 0.0023
969 INJECTION SITE BRUISING 179 0.0022
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122 0.0022
971 INJECTION SITE PAIN 674 0.0022
972 WITHDRAWAL SYNDROME 90 0.0021
973 ANGER 72 0.0021
974 BREAST CANCER 195 0.0021
975 PRODUCT QUALITY ISSUE 283 0.0021
976 DEVICE BREAKAGE 83 0.0020
977 EXPOSURE DURING PREGNANCY 127 0.0020
978 SUICIDAL IDEATION 186 0.0020
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 403 0.0020
980 PSORIASIS 247 0.0019
981 DERMATITIS ATOPIC 98 0.0019
982 SKIN IRRITATION 81 0.0018
983 INJECTION SITE SWELLING 134 0.0017
984 PRODUCT SUBSTITUTION ISSUE 95 0.0016
985 INJECTION SITE REACTION 111 0.0016
986 DRUG WITHDRAWAL SYNDROME 139 0.0016
987 PROSTATE CANCER 109 0.0014
988 SKIN BURNING SENSATION 97 0.0014
989 DEVICE DIFFICULT TO USE 87 0.0013
990 ACNE 99 0.0013
991 NO ADVERSE EVENT 225 0.0012
992 DRUG ABUSE 103 0.0012
993 DRUG DEPENDENCE 183 0.0011
994 ACCIDENTAL EXPOSURE TO PRODUCT 113 0.0011
995 PRODUCT STORAGE ERROR 76 0.0009